11 août 2020 - The US enters into a $1.5B deal with Moderna for 100 million doses of mRNA-1273, their lead candidate vaccine, to be priced at $15 per dose. The Phase III trial is still underway.
Ajouté au bande de temps:
Date:
11 août 2020
Maintenaint
~ Il y a 3 ans et 10 mois
